← Leaderboards
Tova Bergsten
University Of Illinois At Chicago
$209,456
Attributed
$209,456
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$209,456 · 1
By mechanism
F30$209,456 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Igor B Roninson$18,517,458
- Joanna E Burdette$8,615,329
- Lisa Tussing-Humphreys$6,306,920
- Pradip Raychaudhuri$16,086,722
- Jonathan Coppeta$1,986,049
Others in their field
Other Emerging Leaders on “Drug Repurposing”
- Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru$9,927,901
- Lisa M Barroilhet · University Of Wisconsin-Madison$4,654,929
- Julie E Bauman · University Of Arizona$4,424,703
- Bin Chen · University Of California, San Francisco$4,366,375
- William H. Peranteau · Children'S Hosp Of Philadelphia$3,945,125
- Jiang Bian · Weill Medical Coll Of Cornell Univ$3,768,092
Research focus
Drug RepurposingEpithelial CellsAdverse EffectsAdrenergic AgentsAdvanced DiseaseEarly InterventionBeta-2 Adrenergic ReceptorsBeta-Adrenergic ReceptorAnabolismCancer BiologyCancer PatientCellsChemopreventionClinical ManagementClinical PracticeCoculture TechniquesCommunicationCostCrispr/Cas TechnologyCuesDiagnosisDisease ProgressionDistant MetastasisEvent
Grant awards (4)
Regulation of primary metastasis in high grade serous ovarian cancer$53,974
F30 · FY2024 · CA · contact PI
Regulation of primary metastasis in high grade serous ovarian cancer$52,694
F30 · FY2023 · CA · contact PI
Regulation of primary metastasis in high grade serous ovarian cancer$51,752
F30 · FY2022 · CA · contact PI
Regulation of primary metastasis in high grade serous ovarian cancer$51,036
F30 · FY2021 · CA · contact PI